COVID-19-Related Outcomes in Primary Mitochondrial Diseases An International Study

被引:9
|
作者
Pizzamiglio, Chiara [1 ,2 ]
Machado, Pedro M. [1 ,2 ]
Thomas, Rhys H. [3 ]
Gorman, Grainne S. [3 ]
McFarland, Robert [3 ]
Hanna, Michael G. [1 ,2 ]
Pitceathly, Robert D. S. [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London, England
[2] Natl Hosp Neurol & Neurosurg, London, England
[3] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
D O I
10.1212/WNL.0000000000200240
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives To identify factors associated with severe coronavirus disease 2019 (COVID-19), defined by hospitalization status, in patients with primary mitochondrial diseases (PMDs), thereby enabling future risk stratification and informed management decisions. Methods We undertook a cross-sectional, international, registry-based study. Data were extracted from the International Neuromuscular COVID-19 Database and collected between May 1, 2020, and May 31, 2021. The database included subjects with (1) PMD diagnosis (any age), clinically/histopathologically suspected and/or genetically confirmed; and (2) COVID-19 diagnosis classified as "confirmed", "probable", or "suspected" based on World Health Organization definitions. The primary outcome was hospitalization because of COVID-19. We collected demographic information, smoking status, coexisting comorbidities, outcomes after COVID-19 infection, and PMD genotype-phenotype. Baseline status was assessed using the modified Rankin scale (mRS) and the Newcastle Mitochondrial Disease Adult Scale (NMDAS). Results Seventy-nine subjects with PMDs from 10 countries were included (mean age 41.5 +/- 18 years): 25 (32%) were hospitalized, 48 (61%) recovered fully, 28 (35%) improved with sequelae, and 3 (4%) died. Statistically significant differences in hospitalization status were observed in baseline status, including the NMDAS score (p = 0.003) and mRS (p = 0.001), presence of respiratory dysfunction (p < 0.001), neurologic involvement (p = 0.003), and more than 4 comorbidities (p = 0.002). In multivariable analysis, respiratory dysfunction was independently associated with COVID-19 hospitalization (odds ratio, 7.66; 95% CI, 2-28; p = 0.002). Discussion Respiratory dysfunction is an independent risk factor for severe COVID-19 in PMDs while high disease burden and coexisting comorbidities contribute toward COVID-19-related hospitalization. These findings will enable risk stratification and informed management decisions for this vulnerable population.
引用
收藏
页码:576 / 582
页数:7
相关论文
共 50 条
  • [1] COVID-19-Related Pleural Diseases
    Iqbal, Beenish
    Rahman, Najib M.
    Hallifax, Rob J.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (04) : 437 - 446
  • [2] COVID-19-related death and rheumatic diseases
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E174 - E174
  • [3] Primary Aldosteronism and COVID-19-related Management, Disease Severity, and Outcomes: A Retrospective Cohort Study
    Thomas, Teressa S.
    Walpert, Allie R.
    Shen, Grace
    Dunderdale, Carolyn
    Srinivasa, Suman
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (04)
  • [4] Calcifediol Treatment and COVID-19-Related Outcomes
    Nogues, Xavier
    Ovejero, Diana
    Pineda-Moncusi, Marta
    Bouillon, Roger
    Arenas, Dolors
    Pascual, Julio
    Ribes, Anna
    Guerri-Fernandez, Robert
    Villar-Garcia, Judit
    Rial, Abora
    Gimenez-Argente, Carme
    Lourdes Cos, Maria
    Rodriguez-Morera, Jaime
    Campodarve, Isabel
    Manuel Quesada-Gomez, Jose
    Garcia-Giralt, Natalia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (10): : E4017 - E4027
  • [5] COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review
    Drzymalla, Emily
    Green, Ridgely Fisk
    Knuth, Martha
    Khoury, Muin J.
    Dotson, W. David
    Gundlapalli, Adi
    CLINICAL IMMUNOLOGY, 2022, 243
  • [6] COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea
    Baek, Moon Seong
    Lee, Min-Taek
    Kim, Won-Young
    Choi, Jae Chol
    Jung, Sun-Young
    PLOS ONE, 2021, 16 (10):
  • [7] Characteristics and outcomes of COVID-19-related strokes: A retrospective study in a tertiary hospital
    Al Qawasmeh, Majdi
    Ahmed, Yaman
    Nsour, Omar
    Hazaimeh, Ethar
    Qarqash, Aref
    Jbarah, Omar
    El-Salem, Khalid
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [8] No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort study
    Demirci, Ibrahim
    Demir, Tevfik
    Dagdelen, Selcuk
    Haymana, Cem
    Tasci, Ilker
    Atmaca, Aysegul
    Ertugrul, Derun
    Ata, Naim
    Sahin, Mustafa
    Salman, Serpil
    Sahin, Ibrahim
    Emral, Rifat
    Unluturk, Ugur
    Cakal, Erman
    Celik, Osman
    Caglayan, Murat
    Satman, Ilhan
    Sonmez, Alper
    INTERNAL MEDICINE JOURNAL, 2022, 52 (03) : 379 - 385
  • [9] CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH COVID-19-RELATED CRITICAL ILLNESS
    Anesi, George
    Jablonski, Juliane
    Harhay, Michael
    Hanish, Asaf
    Heuer, Monica
    Mikkelsen, Mark
    Salmon, John
    Anderson, Brian
    Gutsche, Jacob
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 52 - 52
  • [10] Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis
    Piza, Pedro Maciel de Toledo
    de Freitas, Victor Muniz
    Aguiar-Brito, Isabella
    Calsolari-Oliveira, Barbara Monique
    Rangel, Erika Bevilaqua
    BIOMEDICINES, 2024, 12 (09)